What does this research mean for the field?

Constitutional MLH1 promoter methylation is a rare cause of Lynch Syndrome that presents with highly variable clinical features, including tumors not classically associated with the syndrome such as breast cancer and dermal lipofibroma. Novelty: ClaimNovelty.INCREMENTAL. Consensus alignment: ConsensusAlignment.NEUTRAL.

What question did this study set out to answer?

The aim is to explore the implications of constitutional MLH1 methylation in tumors with Lynch syndrome phenotypes.

June 5, 2026European Journal of Human GeneticsOpen Access

Constitutional methylation of the MLH1 promoter: a case series including tumors not typically caused by Lynch Syndrome

View Full Paper

Ask AI

Bookmark

Authors

LGLise Graversen JAJannie Assenholt IPInge Søkilde Pedersen

Discussion

Member takes

Overview

Case series reveals constitutional MLH1 methylation in tumors not typically caused by Lynch syndrome, suggesting the need for heightened awareness.

Key Points

The aim is to explore the implications of constitutional MLH1 methylation in tumors with Lynch syndrome phenotypes.
Presented cases of four unrelated patients from Denmark and Australia
Conducted immunohistochemistry and genomic analysis
Assessed clinical features and MLH1 promoter methylation status
Two patients exhibited MLH1 methylation levels indicating mosaicism
Clinical presentations varied and included breast cancer and dermal lipofibroma
Findings highlight the challenge in distinguishing these cases from classic Lynch syndrome

Cite This Study

Graversen et al. (2026) studied this question.

synapsesocial.com/papers/6a22698b763171746d548242 https://doi.org/10.1038/s41431-026-02149-z

View Full Paper

Ask AI

Bookmark

June 5, 2026European Journal of Human GeneticsOpen Access

Constitutional methylation of the MLH1 promoter: a case series including tumors not typically caused by Lynch Syndrome

View Full Paper

Ask AI

Bookmark

Authors

LGLise Graversen JAJannie Assenholt IPInge Søkilde Pedersen

Discussion

Member takes

Overview

Case series reveals constitutional MLH1 methylation in tumors not typically caused by Lynch syndrome, suggesting the need for heightened awareness.

Key Points

The aim is to explore the implications of constitutional MLH1 methylation in tumors with Lynch syndrome phenotypes.
Presented cases of four unrelated patients from Denmark and Australia
Conducted immunohistochemistry and genomic analysis
Assessed clinical features and MLH1 promoter methylation status
Two patients exhibited MLH1 methylation levels indicating mosaicism
Clinical presentations varied and included breast cancer and dermal lipofibroma
Findings highlight the challenge in distinguishing these cases from classic Lynch syndrome

Cite This Study

Graversen et al. (2026) studied this question.

synapsesocial.com/papers/6a22698b763171746d548242 https://doi.org/10.1038/s41431-026-02149-z

View Full Paper

Ask AI

Bookmark